34 min listen
Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery
Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery
ratings:
Length:
27 minutes
Released:
Oct 14, 2017
Format:
Podcast episode
Description
In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery. For more in-depth interviews on the business applications of artificial intelligence, find us online at: www.TechEmergence.com
Released:
Oct 14, 2017
Format:
Podcast episode
Titles in the series (100)
Tim Stevens - Beyond Google Glass: Augmentation, Virtual Reality, and the Future of Personal Security: Tim Stevens is Editor in Chief at Engadget, and he's one of the first people outside of Google to wear Google Glass. In this podcast, Tim talks about his experience with "Glass" (as it is often called), in addition to some potential visions of future... by The AI in Business Podcast